Most healthcare organizations already have access to much of the data they need, but the challenge is operationalizing it ...
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India Our preliminary study found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results